Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

In-Wha Kim

Showing results (51-60 of 103) with videos related to

Pageof 11
Sort By:
International Journal of Environmental Research and Public Health|October 27, 2022
Carfilzomib's Real-World Safety Outcomes in Korea: Target Trial Emulation Study Using Electronic Health RecordsHa Young Jang, Hyun Kyung Lee, Chae Jeong Kim, et al.
Journal of Pharmaceutical Sciences|November 16, 2002
P-glycoprotein-mediated transport of berberine across Caco-2 cell monolayersHan-Joo Maeng, Ho-Jung Yoo, In-Wha Kim, et al.
The Annals of Pharmacotherapy|March 31, 2015
Population pharmacokinetics of cyclosporine in hematopoietic stem cell transplant patients: consideration of genetic polymorphismsMyeong Gyu Kim, In-Wha Kim, Boyoon Choi, et al.
Drug Design, Development and Therapy|July 29, 2016
Pharmacogenetic analysis of cinacalcet response in secondary hyperparathyroidism patientsSohyun Jeong, In-Wha Kim, Kook-Hwan Oh, et al.
Pharmacogenetics and Genomics|March 18, 2026
Application of risk priority number of failure mode and effects analysis to drug-variant pairs for severe cutaneous adverse reactions in Korean and American populationsHyun Kyung Lee, Min Ju Kang, Hajung Kim, et al.
Clinical Therapeutics|July 17, 2012
ABCB1 C3435T genetic polymorphism on population pharmacokinetics of methotrexate after hematopoietic stem cell transplantation in Korean patients: a prospective analysisIn-Wha Kim, Hwi-yeol Yun, Boyoon Choi, et al.
Therapeutics and Clinical Risk Management|September 2, 2017
Effect of additive calcium administration on FGF23 levels in patients with mild chronic kidney disease treated with calcitriol: a randomized, open-labeled clinical trialNayoung Han, Su Hyun Hong, Yon Su Kim, et al.
Pharmacogenomics|October 1, 2015
Population pharmacokinetics and pharmacodynamics of busulfan with GSTA1 polymorphisms in patients undergoing allogeneic hematopoietic stem cell transplantationBoyoon Choi, Myeong Gyu Kim, Nayoung Han, et al.
Therapeutics and Clinical Risk Management|December 5, 2017
Statin therapy for preventing cardiovascular diseases in patients treated with tacrolimus after kidney transplantationNayoung Han, Seung Hee Han, Yun-Kyoung Song, et al.
Frontiers in Nutrition|April 20, 2023
Clinical impacts of the concomitant use of L-asparaginase and total parenteral nutrition containing L-aspartic acid in patients with acute lymphoblastic leukemiaMinoh Ko, Myeong Gyu Kim, Sung-Soo Yoon, et al.
Pageof 11

Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
International Journal of Environmental Research and Public Health|October 27, 2022
Carfilzomib's Real-World Safety Outcomes in Korea: Target Trial Emulation Study Using Electronic Health RecordsHa Young Jang, Hyun Kyung Lee, Chae Jeong Kim, et al.
Journal of Pharmaceutical Sciences|November 16, 2002
P-glycoprotein-mediated transport of berberine across Caco-2 cell monolayersHan-Joo Maeng, Ho-Jung Yoo, In-Wha Kim, et al.
The Annals of Pharmacotherapy|March 31, 2015
Population pharmacokinetics of cyclosporine in hematopoietic stem cell transplant patients: consideration of genetic polymorphismsMyeong Gyu Kim, In-Wha Kim, Boyoon Choi, et al.
Drug Design, Development and Therapy|July 29, 2016
Pharmacogenetic analysis of cinacalcet response in secondary hyperparathyroidism patientsSohyun Jeong, In-Wha Kim, Kook-Hwan Oh, et al.
Pharmacogenetics and Genomics|March 18, 2026
Application of risk priority number of failure mode and effects analysis to drug-variant pairs for severe cutaneous adverse reactions in Korean and American populationsHyun Kyung Lee, Min Ju Kang, Hajung Kim, et al.
Clinical Therapeutics|July 17, 2012
ABCB1 C3435T genetic polymorphism on population pharmacokinetics of methotrexate after hematopoietic stem cell transplantation in Korean patients: a prospective analysisIn-Wha Kim, Hwi-yeol Yun, Boyoon Choi, et al.
Therapeutics and Clinical Risk Management|September 2, 2017
Effect of additive calcium administration on FGF23 levels in patients with mild chronic kidney disease treated with calcitriol: a randomized, open-labeled clinical trialNayoung Han, Su Hyun Hong, Yon Su Kim, et al.
Pharmacogenomics|October 1, 2015
Population pharmacokinetics and pharmacodynamics of busulfan with GSTA1 polymorphisms in patients undergoing allogeneic hematopoietic stem cell transplantationBoyoon Choi, Myeong Gyu Kim, Nayoung Han, et al.
Therapeutics and Clinical Risk Management|December 5, 2017
Statin therapy for preventing cardiovascular diseases in patients treated with tacrolimus after kidney transplantationNayoung Han, Seung Hee Han, Yun-Kyoung Song, et al.
Frontiers in Nutrition|April 20, 2023
Clinical impacts of the concomitant use of L-asparaginase and total parenteral nutrition containing L-aspartic acid in patients with acute lymphoblastic leukemiaMinoh Ko, Myeong Gyu Kim, Sung-Soo Yoon, et al.
Pageof 11